11th Edition Medical Device Project and Portfolio Management

Medical device organizations are under increasing pressure to deliver more innovation with fewer resources while navigating regulatory complexity, rising development costs, portfolio congestion, and growing demands for faster commercialization. Despite investments in Enterprise PMOs, portfolio governance, and digital PPM platforms, many organizations still struggle with strategic alignment, portfolio visibility, resource capacity planning, and cross-functional decision-making. This conference brings together PMO, portfolio, R&D, quality, regulatory, and business leaders to strengthen portfolio prioritization, optimize resource allocation, improve governance frameworks, and leverage AI-enabled decision intelligence. Through practical case studies and peer-led discussions, attendees will explore how to build resilient, data-driven portfolios that accelerate innovation, improve decision quality, and deliver measurable business outcomes.

The Marcus Evans 11th Edition Medical Device Project and Portfolio Management conference will explore how MedTech leaders across portfolio, R&D & regulatory to translate strategy into measurable business outcomes. Sessions will explore responsible AI, capacity and capability planning, single-source-of-truth ecosystems, and Strategic Realization Offices that close the gap between executive expectations and delivery reality while also exploring methods to decongest portfolios, embed enterprise risk vocabularies, align regulatory intelligence early, and rationalize lifecycle investments and end-of-life decisions. The agenda will also deliver actionable insights on scenario modeling, feasibility funnels, KPI discipline, and cross-functional governance that accelerate time-to-market, improve ROI, and strengthen resilience amid MDR shifts, supply shocks, and geopolitical volatility.

Topics Covered:

• Optimize portfolio investments across innovation and business-critical initiatives for improving portfolio performance 

• Rationalize portfolio investments for eliminating low-value projects and accelerating strategic outcomes 

• Integrate risk management into portfolio governance for strengthening decision quality

• Evaluate emerging growth opportunities for expanding market presence and long-term competitiveness 

• Build resilient portfolio strategies for managing supply chain, geopolitical and market disruptions 

• Build enterprise-wide prioritization and portfolio scoring models for improving funding decisions across business units 

Best Practices and Case Studies from:

• Mahesh Chaubal, Vice President Infusion Therapies & Platforms R&D, Baxter

• Danijel Brener, Vice President, Head of Enterprise PMO, Philips Sleep & Respiratory Care, Philips 

• Sandeep Dhar, Senior Director- Center Global Category Management Leader (Supply Chain Procurement), Johnson & Johnson MedTech

• Taylor Williams, Director, Integrated Business Planning - Core Surgical Innovations, Medtronic 

• Jonathan Cote, Director, Portfolio Value Improvement, BD

• Jamie Walker, Director of Project Management, Vision Care Portfolio, Alcon

Special discounts available to BioFocus UK readers. For more information please contact: Stefanos Ioannou, Digital Media and PR Executive at stefanosi@marcusevanscy.com  or visit: https://tinyurl.com/9u5wdzs4